Plain-English translation of NCT06410001 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
CE-STAND is testing a device called the Abbott Eterna epidural stimulator system, which is surgically implanted near the spinal cord to deliver gentle electrical stimulation. The goal is to help people with cervical (neck-level) spinal cord injuries recover some movement, improve bladder and bowel function, and enhance their overall quality of life. Researchers will compare how participants function with the stimulator turned on and turned off over the course of one year.
Cervical spinal cord injuries often cause severe weakness in the arms and loss of control over bladder, bowel, and sexual function, greatly limiting quality of life. While electrical spinal cord stimulation has shown promise in helping some people with spinal cord injuries, there has been very little research on whether it works for cervical injuries and autonomic (involuntary body function) problems—this trial aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
You would have surgery to implant the Abbott Eterna epidural stimulator system, a small device that sits near your spinal cord. Over the following year, you would return for visits every three months (roughly 4 main visits) where doctors will test different stimulation settings—up to 15 different combinations—to find the ones that work best for you. You'll be tested with the stimulator turned on and off to measure changes in your movement, bladder and bowel control, and overall quality of life, and the study team will use special computer tools to identify your optimal settings.
AI-generated summary from trial data · Aug 27, 2026 · Not medical advice
United States
Phase
Safety & dosing / Early efficacy
Sponsor
University of Minnesota
Enrollment target
~36 participants
Started
March 2026
Primary completion
May 2030
Age range
22 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ann Parr, MD, PhD
University of Minnesota
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.